Browse studies

Find your next paid study

5 recruiting studies matching your filters

A Multinational, Long-Term, Safety and Tolerability, Open-Label Extension Study of Subjects Who Have Participated in Avalyn Pharma Studies of Inhaled Antifibrotic Agents (AP-LTE-008 [SAIL])

This is an open-label extension study for participants who were previously enrolled in and completed an Avalyn Pharma Sponsored study with an inhaled antifibro…

Progressive Pulmonary FibrosisIdiopathic Pulmonary Fibrosis (IPF)

Estimated

~$10 – $8,750

Avalyn Pharma Inc.NCT06951217

Pulmonary Fibrosis Foundation Community Registry

Pulmonary fibrosis (PF) results from a diverse group of health conditions and affects the lives of patients (including those who are post lung transplant), car…

Pulmonary FibrosisInterstitial Lung DiseaseLung Fibrosis+2 more

Estimated

~$10 – $750

Pulmonary Fibrosis FoundationNCT05382572

Observational

Feasibility and Acceptability of a Mobile Application "SUPPORT-T" to Increase Equitable Access to Palliative Care in Patients With Progressive Pulmonary Fibrosis (PPF) and Their Caregivers

This pilot randomized controlled trial evaluates the feasibility, acceptability, and accessibility of SUPPORT-T, a digitally delivered palliative care interven…

Progressive Pulmonary FibrosisInterstitial Lung Disease

Estimated

~$10 – $6,250

Medical University of South CarolinaNCT07269262

PRIME-PPF: PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

This is a prospective, observational cohort study. Participants with non-idiopatic pulmonary fibrosis, interstitial lung disease (ILD) will be followed for 24 …

Progressive Pulmonary FibrosisInterstitial Lung Disease

Estimated

~$10 – $750

University of Massachusetts, WorcesterNCT06855329

Phase 3

A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

Study RIN-PF-305 is designed to evaluate the safety and efficacy of inhaled treprostinil in subjects with progressive pulmonary fibrosis (PPF) over a 52-week p…

Progressive Pulmonary FibrosisInterstitial Lung Disease

Estimated

~$10 – $8,750

United TherapeuticsNCT05943535